🚀 VC round data is live in beta, check it out!
China Resources Sanjiu Valuation Multiples
Discover revenue and EBITDA valuation multiples for China Resources Sanjiu and similar public comparables like Bachem, Arcellx, Protagonist Therapeutics, Belite Bio and more.
China Resources Sanjiu Overview
About China Resources Sanjiu
China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. The company operates through three primary segments. The Pharmaceutical Industry segment focuses on manufacturing consumer health (CHC) products, dietary supplements, traditional Chinese medicine health items, and prescription medications. The Printing and Packaging segment handles the design, printing, and packaging of various materials. The Pharmaceuticals, equipment, wholesale, and retail industry segment involves the distribution and sale of pharmaceuticals and medical devices. Products are mainly marketed under the 999 brand, with operations spanning both domestic and international markets.
Founded
1999
HQ
Employees
20.0K
Website
Sectors
Financials (LTM)
EV
$6B
China Resources Sanjiu Financials
China Resources Sanjiu reported last 12-month revenue of $5B and EBITDA of $861M.
In the same LTM period, China Resources Sanjiu generated $3B in gross profit, $861M in EBITDA, and $512M in net income.
Revenue (LTM)
China Resources Sanjiu P&L
In the most recent fiscal year, China Resources Sanjiu reported revenue of $5B and EBITDA of $928M.
China Resources Sanjiu expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $5B | XXX | $5B | XXX | XXX | XXX |
| Gross Profit | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Margin | 55% | XXX | 54% | XXX | XXX | XXX |
| EBITDA | $861M | XXX | $928M | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 20% | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| Net Profit | $512M | XXX | $502M | XXX | XXX | XXX |
| Net Margin | 11% | XXX | 11% | XXX | XXX | XXX |
| Net Debt | — | — | $185M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
China Resources Sanjiu Stock Performance
China Resources Sanjiu has current market cap of $7B, and enterprise value of $6B.
Market Cap Evolution
China Resources Sanjiu's stock price is $4.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $7B | -1.2% | XXX | XXX | XXX | $0.30 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialChina Resources Sanjiu Valuation Multiples
China Resources Sanjiu trades at 1.4x EV/Revenue multiple, and 7.5x EV/EBITDA.
EV / Revenue (LTM)
China Resources Sanjiu Financial Valuation Multiples
As of April 18, 2026, China Resources Sanjiu has market cap of $7B and EV of $6B.
Equity research analysts estimate China Resources Sanjiu's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
China Resources Sanjiu has a P/E ratio of 13.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $7B | XXX | $7B | XXX | XXX | XXX |
| EV (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 7.5x | XXX | 7.0x | XXX | XXX | XXX |
| EV/EBIT | 9.2x | XXX | 9.2x | XXX | XXX | XXX |
| EV/Gross Profit | 2.5x | XXX | 2.6x | XXX | XXX | XXX |
| P/E | 13.1x | XXX | 13.4x | XXX | XXX | XXX |
| EV/FCF | 15.4x | XXX | 10.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified China Resources Sanjiu Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
China Resources Sanjiu Margins & Growth Rates
China Resources Sanjiu's revenue in the last 12 month grew by 8%.
China Resources Sanjiu's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
China Resources Sanjiu's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
China Resources Sanjiu's rule of X is 38% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
China Resources Sanjiu Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 1% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 26% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 38% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 29% | XXX | 29% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 6% | XXX | 6% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | 4% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 39% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
China Resources Sanjiu Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| China Resources Sanjiu | XXX | XXX | XXX | XXX | XXX | XXX |
| Bachem | XXX | XXX | XXX | XXX | XXX | XXX |
| Arcellx | XXX | XXX | XXX | XXX | XXX | XXX |
| Protagonist Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Belite Bio | XXX | XXX | XXX | XXX | XXX | XXX |
| Glenmark Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
China Resources Sanjiu M&A Activity
China Resources Sanjiu acquired XXX companies to date.
Last acquisition by China Resources Sanjiu was on XXXXXXXX, XXXXX. China Resources Sanjiu acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by China Resources Sanjiu
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialChina Resources Sanjiu Investment Activity
China Resources Sanjiu invested in XXX companies to date.
China Resources Sanjiu made its latest investment on XXXXXXXX, XXXXX. China Resources Sanjiu invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by China Resources Sanjiu
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout China Resources Sanjiu
| When was China Resources Sanjiu founded? | China Resources Sanjiu was founded in 1999. |
| Where is China Resources Sanjiu headquartered? | China Resources Sanjiu is headquartered in China. |
| How many employees does China Resources Sanjiu have? | As of today, China Resources Sanjiu has over 20K employees. |
| Is China Resources Sanjiu publicly listed? | Yes, China Resources Sanjiu is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of China Resources Sanjiu? | China Resources Sanjiu trades under 000999 ticker. |
| When did China Resources Sanjiu go public? | China Resources Sanjiu went public in 2000. |
| Who are competitors of China Resources Sanjiu? | China Resources Sanjiu main competitors are Bachem, Arcellx, Protagonist Therapeutics, Belite Bio. |
| What is the current market cap of China Resources Sanjiu? | China Resources Sanjiu's current market cap is $7B. |
| What is the current revenue of China Resources Sanjiu? | China Resources Sanjiu's last 12 months revenue is $5B. |
| What is the current revenue growth of China Resources Sanjiu? | China Resources Sanjiu revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of China Resources Sanjiu? | Current revenue multiple of China Resources Sanjiu is 1.4x. |
| Is China Resources Sanjiu profitable? | Yes, China Resources Sanjiu is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of China Resources Sanjiu? | China Resources Sanjiu's last 12 months EBITDA is $861M. |
| What is China Resources Sanjiu's EBITDA margin? | China Resources Sanjiu's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of China Resources Sanjiu? | Current EBITDA multiple of China Resources Sanjiu is 7.5x. |
| What is the current FCF of China Resources Sanjiu? | China Resources Sanjiu's last 12 months FCF is $421M. |
| What is China Resources Sanjiu's FCF margin? | China Resources Sanjiu's last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of China Resources Sanjiu? | Current FCF multiple of China Resources Sanjiu is 15.4x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.